THERAPEUTIC AREA PORTFOLIO · 6 PRODUCTS
Respiratory & Rare Disease
The portfolio connects respiratory programs represented by cystic-fibrosis and leukotriene-pathway therapies with selected rare-disease programs present in the product catalog.
Target APIs & Active Pipeline Programs in Respiratory & Rare Disease
Respiratory & Rare Disease Products (6)
Catalog products related to terminal APIs in this area.
CP-ELEX-01CAS 1897428-40-8
(S)-2,2,4-trimethylpyrrolidinehydrochlorideTarget API: Elexacaftor (VX-445)
CP-ELEX-03CAS 2229861-15-6
3-(3,3,3-Trifluoro-2,2-dimethylpropoxy)-1H-pyrazoleTarget API: Elexacaftor (VX-445)
CP-MONT-01CAS 142569-70-8
2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanolTarget API: Montelukast
![Chemical structure of 2-[1-(Mercaptomethyl)cyclopropyl]acetic acid](/images/structures/H-08.svg)